Figure 3.
Percentage frequency of T2DM according to low-density-lipoprotein cholesterol (LDL-C) levels of participants with or without using lipid-lowering drugs. Multiple logistic regression analysis was adopted for investigating the contribution of LDL-C levels to prevalence of T2DM. Odds ratios (ORs) for different levels compared to the highest (≥160) were adjusted for age, sex, MoCA, IADL, triglyceride, cerebrovascular diseases, hypertension, dyslipidemia, coronary artery diseases, congestive heart failure, atherosclerosis, smoking, exercise, antihypertensives, lipid-lowering drugs, antiplatelets, and anticoagulants. ns: nonsignificance, p > 0.05.